| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-01-28 Tx date 2019-01-25 |
$KALY
Kalytera Therapeutics, Inc. |
Rudman, Victoria Diana
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
897,360 | |
| Filed 2019-01-28 Tx date 2019-01-25 |
$KALY
Kalytera Therapeutics, Inc. |
Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,246,092 vol |
13,870,849 | |
| Filed 2019-01-28 Tx date 2019-01-25 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+1,129,318 vol |
4,141,083 | |
| Filed 2019-01-28 Tx date 2019-01-25 |
$KALY
Kalytera Therapeutics, Inc. |
paley, jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,129,318 vol |
3,761,618 | |
| Filed 2018-09-27 Tx date 2018-09-24 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+1,262,475 vol |
3,011,765 | |
| Filed 2018-09-27 Tx date 2018-09-24 |
$KALY
Kalytera Therapeutics, Inc. |
paley, jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,262,475 vol |
2,632,300 | |
| Filed 2018-09-27 Tx date 2018-09-24 |
$KALY
Kalytera Therapeutics, Inc. |
Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,117,794 vol |
12,624,757 | |
| Filed 2018-09-27 Tx date 2018-09-24 |
$KALY
Kalytera Therapeutics, Inc. |
Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,262,475 vol |
1,758,941 | |
| Filed 2018-09-27 Tx date 2018-09-24 |
$KALY
Kalytera Therapeutics, Inc. |
Rudman, Victoria Diana
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
597,360 | |
| Filed 2018-01-31 Tx date 2018-01-30 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+326,000 vol |
1,749,290 | |
| Filed 2018-01-31 Tx date 2018-01-30 |
$KALY
Kalytera Therapeutics, Inc. |
Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+326,000 vol |
496,466 | |
| Filed 2018-01-31 Tx date 2018-01-30 |
$KALY
Kalytera Therapeutics, Inc. |
paley, jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+326,000 vol |
1,369,825 | |
| Filed 2018-01-31 Tx date 2018-01-30 |
$KALY
Kalytera Therapeutics, Inc. |
Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,045,210 vol |
7,506,963 | |
| Filed 2017-12-06 Tx date 2017-10-08 |
$KALY
Kalytera Therapeutics, Inc. |
paley, jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,022,610 vol |
||
| Filed 2017-12-06 Tx date 2017-10-08 |
$KALY
Kalytera Therapeutics, Inc. |
paley, jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,022,610 vol |
||
| Filed 2017-12-06 Tx date 2017-10-08 |
$KALY
Kalytera Therapeutics, Inc. |
paley, jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+681,740 vol |
1,043,825 | |
| Filed 2017-12-06 Tx date 2017-10-08 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+1,022,610 vol |
1,423,290 | |
| Filed 2017-12-06 Tx date 2017-10-08 |
$KALY
Kalytera Therapeutics, Inc. |
Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,473,442 vol |
6,461,753 | |
| Filed 2017-12-06 Tx date 2016-12-30 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Rutkowski Family Trust (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+308,764 vol |
308,764 | |
| Filed 2017-12-06 Tx date 2016-12-30 |
$KALY
Kalytera Therapeutics, Inc. |
Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Rutkowski Family Trust (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+304,764 vol |